Hundreds of thousands of Americans have a spinal cord injury that’s impacting their mobility and daily living. So far, there hasn’t been an effective treatment that repairs nerve connections and muscle function. However, our expert discusses a new option that, if FDA approved, could be a gamechanger for patients.
Guest Information:
- Dr. Daniel Mikol, Chief Medical Officer, NervGen Pharma Corp.
Leave a Reply